JSA Advised TPG Growth In GIC’s Further Acquisition In Asia Healthcare Holdings
JSA Advised TPG Growth In GIC’s Further Acquisition In Asia Healthcare Holdings
JSA advised TPG Growth entities (collectively, “TPG Growth”) in further investment by Waverly Pte. Ltd. (“GIC”) in Asia Healthcare Holdings Pte. Ltd., a healthcare delivery platform backed by TPG Growth and GIC.
The Merger and Acquisition Team Comprised Lead Partner and National Corporate Lead – Iqbal Khan, Partners – Ambarish . and Tanavi Mohanty, Principal Associate – Krishaal Morjaria, Senior Associate – Soumya Pradhan, Associate – Subham Biswal.
The Competition Team Partner and Chair, Competition Law Practice – Nisha Kaur Uberoi, Partner – Pranav Satyam, Principal Associate – Anand Sree, Senior Associates – Kamal Sharma and Ishan Arora, Associates – Giri Aravind and Sudhanshu Prakash Singh.
Source: JSA’s LinkedIn Page
JSA Advised TPG In Proposed Merger Of QCIL With Aster DM Healthcare
JSA advised TPG, in relation to the proposed merger of its investee company, Quality Care India Limited (“QCIL”), with Aster DM Healthcare Limited (“Aster”), at a combined valuation of over USD 5 billion.
The transaction also contemplates a preferential issuance by Aster, prior to the merger, for an acquisition of 5% shareholding in QCIL. The transactions are subject to applicable regulatory and corporate approvals.
The combined entity will have a network of 38 hospitals and 10,150+ beds spread across 27 cities making it one of the top 3 hospital chains in India. Deal value: USD 5 billion (approx.)
Our transaction team comprises Lead Partners – Iqbal Khan and Ambarish ., Partner – Ashid Basheer, and Senior Associate – Varun Natarajan.
